Eyeworld

13 October 2016 provides news on association initia- tives and member leadership. Certifications Earning a professional certification is one way administrators can ensure they are familiar with the broad body of knowledge required of prac- tice managers today and be formally recognized among their peers in the field of ophthalmic administra- tion. ASOA provides the training and education to obtain the Certi- fied Ophthalmic Executive (COE) designation. The COE is the national standard for ophthalmic practice management and is an elite certifi- cation that promotes excellence and professionalism in ophthalmic prac- tice management. It is administered by the National Board for the Cer- tification of Ophthalmic Executives (NBCOE). The COE recognizes those who have achieved the experience, knowledge, and skills identified by the NBCOE as essential to practice management. In addition to the COE, ASOA supports the Certified Patient Service Specialist (CPPS) certification, ad- ministered by BSM Consulting, that serves as the national standard of ex- cellence for nonclinical office staff. The CPPS program is an affordable and convenient online certification program. A full listing of member bene- fits and information about joining ASOA can be found on the ASOA website at www.asoa.org. EW Contact information Monasterio: dmonasterio@ascrs.org Industry meetings A major benefit of being an ASOA member is access to leading oph- thalmic administrative meetings throughout the year. Every spring, ASOA, in conjunction with the American Society of Cataract and Refractive Surgery (ASCRS), holds the ASCRS•ASOA Symposium & Congress (the next meeting will be in Los Angeles, on May 5–9, 2017). The meeting includes quality educa- tion for practice management staff from leaders in the field. ASOA also hosts a dedicated practice manage- ment track at the Combined Oph- thalmic Symposium in Austin, Texas in conjunction with ASCRS and the American Society of Ophthalmic Registered Nurses (ASORN). In ad- dition to these two meetings, ASOA hosts regional meetings in different locations around the country as part of its ASOA on Tour initiative. ASOA on Tour was developed to provide practice managers with convenient, alternative opportunities for face-to- face education, while still providing the quality level of programming ASOA is known for. Publications ASOA publishes the award-winning Administrative Eyecare magazine six times a year. Each issue addresses topics such as administration and human resources, information tech- nology, coding and reimbursement, and specialties such as ambulatory surgical centers, cosmetic services, hearing services, optical shops, and retina. Each issue also features an in-depth article on a trending topic in ophthalmology management and In the journal ... Influence of blurred vision, accommodation, and target laser settings on eye movements during LASIK Anna Christina Sasse, MD, Mehdi Shajari, MD, Thomas Kohnen, MD In this prospective randomized study, investigators considered how eye movements during LASIK would be affected by blurred vision, accommodation, and target laser settings. Included here were 11 eyes of 11 patients that underwent simulated LASIK treatment. Although the treatment laser was blocked, each patient was told to focus on the fixation light. A soft contact lens that had undergone a 5 D myopic laser treatment placed on the patient's eye was used to simulate blurred vision. A second lens that equaled the patient's spherical equivalent plus an additional 3 D was used to diminish accommodation. Patients were then tested wearing the blurred lens with the target light on and with it turned off and then again wearing the 3 D with the target laser on and off. Investigators determined that only in one variable on the y-axis was there any significant difference in the F80 criterion. They conclud- ed that when it came to eye movements during LASIK, blurred vision, accommodation, and target light had little effect. Surgical treatment of presbyopia with centered presbyopic laser in situ keratomileusis: One-year results Gaëlle Ho Wang Yin, MD, Colm McAlinden, MB BCh, Emmanuelle Pieri, OD, Claire Giulardi, OD, Guillaume Holweck, MD, Louis Hoffart, MD Investigators considered how those treated with centered presbyopic LASIK fared in terms of effectiveness, refractive outcomes, and quality of vision. Included in this prospective study were 138 eyes of 69 hyper- opic patients who underwent this treatment between February 2013 and January 2015. At 1 year postoperatively investigators found that patients treated with this technique had a mean binocular uncorrected distance visual acuity of 20/20, binocular near visual acuity of Jaeger 2, and binocular uncorrected intermediate visual acuity of 20/20. At the 3-month postoperative mark more than 95% said they were satisfied with the surgery, and at 6 months all would recommend this to others. Investigators concluded that for this group of patients, centered presby- opic LASIK with corneal asphericity modulation was a safe and effective presbyopia treatment. Objective evaluation of lens clarity following the intravitreal injection of sustained-release dexamethasone implant: Lens densitometry study Mustafa Alpaslan Anayol, MD, Mehmet Ali Sekeroglu, MD, Hakan Tirhis, MD, Bayram Gulpamuk, MD, Sibel Doguizi, MD, Pelin Yilmazbas, MD The aim of this prospective case series was to determine how treatment with an intravitreal sustained-release dexamethasone implant affected eyes with macular edema occurring after a retinal vein occlusion com- pared to healthy controls. Included here were 37 patients with either branch or central retinal vein occlusion. At the 3-month mark investiga- tors found that there was a significant increase in mean lens densitome- try value at Pentacam (Oculus, Wetzlar, Germany) densitometry zone 1 in study eyes, when compared to baseline values. However, average and maximum lens densitometry values and lens thickness for zones 2 and 3 were similar at baseline and the 3-month post-injection mark, as was the densitometry for control eyes. Investigators concluded that at the 3-month mark after injection of the dexamethasone implant for macu- lar edema treatment, there was a significant increase in the study eyes in mean lens densitometry value at zone 1. October 2016 October 2016 ASCRS update 13

• Cover